UNSPSC 51111834: Bazedoxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C30H34N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q16TT9C5BK, chemically known as 1h-indol-5-ol, 1-((4-(2-(hexahydro-1h-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl- but generally known as bazedoxifene, which bears US NIH Compound Identifier 154257. Bazedoxifene most often comes in basic and acetate forms.

UNSPSC 51111834 Bazedoxifene is a Commodity code for a selective estrogen receptor modulator pharmaceutical, but the source provides no recent state and local contract opportunities soliciting this product. Without posted RFPs, RFQs, IFBs, or ITBs in the records available, no characterization of issuing-body mix, geographic spread, or representative solicitations can be drawn. State and local procurement of branded or proprietary pharmaceuticals typically flows through state formulary programs, group purchasing cooperative agreements, or Department of Health channels rather than open competition; absent specific opportunities in the source, market activity under this code cannot be assessed.

The Commodity code designation and lack of recent activity suggests that bazedoxifene procurement, if it occurs at the state or local level, may be handled through existing standing agreements, state pharmaceutical contracts, or direct purchases by individual agencies rather than new competitive solicitations. Firms targeting this code should monitor state health department and Department of Human Services RFPs for generic pharmaceutical or formulary contracts that may list this product as an allowable supply, and track cooperative purchasing vehicle updates through organizations such as NASPO ValuePoint or state group purchasing organizations that may add this medication to their formularies.